Tag: Cancer: Cervical
Adding Pembrolizumab to Chemo Ups Survival in Cervical Cancer
Progression-free and overall survival significantly longer for patients with persistent, recurrent, metastatic cervical cancer
Globally, Cervical Cancer Incidence, Mortality Stable or Decreasing
Negative correlations seen for cervical cancer incidence and mortality rates with the Human Development Index
Unmet Social Needs, Distress Linked in Gynecologic Oncology Patients
Social isolation and lack of safety at home associated with distress; unmet needs also linked to treatment interruption
Perceived Financial Barriers Hinder Cervical Cancer Screening
72 percent of low-income, uninsured, or publicly insured women perceived financial barriers to screening
Women’s Cancer Screenings Plummeted During Pandemic
Decline especially noticeable among women of racial and ethnic minority groups with low incomes
Many Older Women Not Eligible to Quit Cervical Cancer Screening
Findings consistent among women with employer-based insurance and those treated at a safety net health center
Lower Incomes Increase Cancer Worry, Anxiety During Pandemic
Worry, anxiety up with lower annual income for Medicaid-insured women receiving gynecologic oncology care during March 15 to April 15, 2020
Cervical Cancer Screening Rates Dropped During Stay-at-Home Order
Cervical cytology screening rates per 100 person-months decreased 78 percent among women aged 21 to 29 years
Breast, Cervical, CRC Screening Below Healthy People 2020 Targets
Colorectal cancer test receipt near target in 2018, with 66.9 percent of adults aged 50 to 75 years up to date with testing
Hospitalization Up for Black Gynecologic Cancer Patients With COVID-19
Among patients with gynecologic cancer who died from COVID-19, 41.2 percent were Black